Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid Arthritis

NCT02209779 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

167

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Rheumatoid

Interventions

DRUG: BIBR 796 BS
DRUG: Placebo

Sponsor

Boehringer Ingelheim